Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.32 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including oligodendrocytes; strongest in podocytes | 0.75 |
| chemistry Open Targets | compounds already reach it: t-62, adenosine, caffeine +19 | 1.00 |
| trials ClinicalTrials.gov | 31 Parkinson's trials, 4 stopped | 0.90 |
| literature PubMed | 7 Parkinson's papers of 227 | 0.73 |
| pathways Reactome | 2 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 1117
Sealed predictions
- ADORA1 in oligodendrocytes, braak-0.39 (p 0.300) → -0.52 (p 0.154)receipt 1123
- ADORA1 in dopamine neurons, braak+0.03 (p 0.946) → -0.41 (p 0.273)receipt 1124
Swarm cases
receipt 1124: ADORA1 in dopamine neurons, braak
- power
- full sample -0.15 (p 0.561, n 18), 95% CI -0.57 to +0.34. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.14 (p 0.579, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.50 (p 0.034, n 18). not the mix.
- skeptic
- leave-one-out range -0.24 to -0.03, sign flips 0; without severely affected donors -0.15 (p 0.561, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADORA1 in dopamine neurons.
case closed: nothing better to follow up.
receipt 1123: ADORA1 in oligodendrocytes, braak
- power
- full sample -0.50 (p 0.035, n 18), 95% CI -0.78 to -0.04. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.49 (p 0.041, n 18). holds up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.57 (p 0.013, n 18). not the mix.
- skeptic
- leave-one-out range -0.63 to -0.43, sign flips 0; without severely affected donors -0.50 (p 0.035, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADORA1 in oligodendrocytes.
case closed: nothing better to follow up.
Receipts
loading the receipts